An updated review of pharmacokinetic drug interactions and pharmacogenetics of statins

T Hirota, Y Fujita, I Ieiri - Expert Opinion on Drug Metabolism & …, 2020 - Taylor & Francis
Introduction Hydroxymethylglutaryl-coenzyme A reductase inhibitors (statins) lower
cholesterol synthesis in patients with hypercholesterolemia. Increased statin exposure is an …

Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation

GF Watts, S Gidding, AS Wierzbicki, PP Toth… - International journal of …, 2014 - Elsevier
Familial hypercholesterolaemia (FH) is a dominantly inherited disorder present from birth
that markedly elevates plasma low-density lipoprotein (LDL) cholesterol and causes …

Secondary prevention after coronary artery bypass graft surgery: a scientific statement from the American Heart Association

A Kulik, M Ruel, H Jneid, TB Ferguson, LF Hiratzka… - Circulation, 2015 - Am Heart Assoc
The recommendations listed in this document are, whenever possible, evidence based.
Writing group members performed these relevant supplemental literature searches with key …

Recommendations for management of clinically significant drug-drug interactions with statins and select agents used in patients with cardiovascular disease: a …

BS Wiggins, JJ Saseen, RL Page, BN Reed, K Sneed… - Circulation, 2016 - Am Heart Assoc
A n D GUID eLIneS affordability may often dictate which medications may be prescribed.
Patients who have exhausted prescription drug coverage or who are uninsured may require …

JCS/JSCVS 2018 guideline on revascularization of stable coronary artery disease

M Nakamura, H Yaku, J Ako, H Arai, T Asai… - Circulation …, 2022 - jstage.jst.go.jp
The Japanese Circulation Society (JCS) published the “Guidelines for elective percutaneous
coronary intervention [PCI] in patients with stable coronary disease” in 2000. In 2006 …

Statin-induced myopathy: a review and update

TT Abd, TA Jacobson - Expert opinion on drug safety, 2011 - Taylor & Francis
Introduction: Statin-induced myopathy is an important cause of statin intolerance and the
most common cause of statin discontinuation. Observational studies estimate that 10–15 …

Statin drug interactions and related adverse reactions: an update

S Bellosta, A Corsini - Expert opinion on drug safety, 2018 - Taylor & Francis
Introduction: Statins reduce the risk of cardiovascular morbidity and mortality in patients with
or at risk for cardiovascular disease and their use is expanding, especially in elderly. Statins …

Association of statin use with peripheral neuropathy in the US population 40 years of age or older (美国40 岁及以上人群的他汀使用情况与周围神经病变的关系)

EF Tierney, DJ Thurman, GL Beckles… - Journal of …, 2013 - Wiley Online Library
摘要背景周围神经病变是一种严重的糖尿病并发症, 在某些情况下可导致下肢丧失功能甚至截肢
. 自从他汀类药物问世以来, 其使用日益增加. 最近的报告表明他汀类药物可以影响周围神经病变 …

Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease

B Wolozin, SW Wang, NC Li, A Lee, TA Lee, LE Kazis - BMC medicine, 2007 - Springer
Background Statins are a class of medications that reduce cholesterol by inhibiting 3-
hydroxy-3-methylglutaryl-coenzyme A reductase. Whether statins can benefit patients with …

The metabolic syndrome—from insulin resistance to obesity and diabetes

EJ Gallagher, D LeRoith, E Karnieli - Endocrinology and metabolism clinics …, 2008 - Elsevier
In today's society with the escalating levels of obesity, diabetes, and cardiovascular disease,
the metabolic syndrome is receiving considerable attention and is the subject of much …